Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence

被引:128
|
作者
Williams, L. Keoki
Joseph, Christine L.
Peterson, Edward L.
Wells, Karen
Wang, Mingqun
Chowdhry, Vimal K.
Walsh, Matthew
Campbell, Janis
Rand, Cynthia S.
Apter, Andrea J.
Lanfear, David E.
Tunceli, Kaan
Pladevall, Manel
机构
[1] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Ctr Hlth Serv Res, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA
[4] Hlth Alliance Plan, Detroit, MI USA
[5] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[6] Univ Penn, Med Ctr, Dept Med, Philadelphia, PA 19104 USA
关键词
primary nonadherence; inhaled corticosteroids; asthma race-ethnicity; controller medication;
D O I
10.1016/j.jaci.2007.08.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Adherence to inhaled corticosteroids (ICSs) is known to be poor among patients with asthma; however, little is known about patients who do not fill their ICS prescriptions (ie, primary nonadherence). Objective: To estimate rates of primary nonadherence and to explore associated factors. Methods: The study population was members of a large health maintenance organization in southeast Michigan who met the following criteria: age 5 to 56 years; previous diagnosis of asthma; at least I electronic prescription for an ICS between February 17, 2005, and June 1, 2006; and at least 3 months follow-tip after the ICS prescription. Adherence was estimated by using electronic prescription information and pharmacy claims data. Multivariable stepwise analysis was used to identify factors associated with primary nonadherence compared with adherent patients. Results: One thousand sixty-four patients met the study criteria and bad calculable adherence. Of these patients, 82 (8%) never filled their ICS prescription. Stepwise regression identified the following factors to be associated with an increased likelihood of primary nonadherence: younger age, female sex, African American race-ethnicity, and lower rescue medication use. Factors associated with primary nonadherence differed between race-ethnic groups. Conclusion: Primary nonadherence was associated with lower baseline rescue medication use, which may reflect lower perceived need for ICS therapy in patients with milder asthma. Rates of primary nonadherence and the factors which influenced this outcome differed by race-ethnicity. Clinical implications: Understanding patient characteristics associated with primary nonadherence may be important for disease management, because many patients with asthma do not fill their ICS prescriptions.
引用
收藏
页码:1153 / 1159
页数:7
相关论文
共 50 条
  • [21] An update on the safety of long-acting β-agonists in asthma patients using inhaled corticosteroids
    Salpeter, Shelley R.
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (03) : 407 - 419
  • [22] The Frequency and Risk Factors for Oropharyngeal Candidiasis in Adult Asthma Patients Using inhaled Corticosteroids
    Erdogan, Tuba
    Karakaya, Gul
    Kalyoncu, A. Fuat
    TURKISH THORACIC JOURNAL, 2019, 20 (02) : 136 - 139
  • [23] Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)?
    Overbeek, SE
    Kerstjens, HAM
    Bogaard, JM
    Mulder, PGH
    Postma, DS
    Kerrebijn, KF
    Quanjer, PH
    Sluiter, HJ
    Pouw, EM
    Schoonbrood, DFME
    Roos, CH
    Jansen, HM
    Brand, PLP
    deGooijer, A
    vanderMark, TW
    Koeter, GH
    deJong, PM
    Sterk, PJ
    Wever, AMJ
    Dijkman, JH
    Dekhuijzen, PNR
    Folgering, H
    vanHerwaarden, CLA
    Hilvering, C
    Mengelers, SJ
    Gans, SJ
    vanderBruggen, B
    Kreukniet, J
    vanEssenZandvliet, EEM
    Duiverman, EJ
    Kouwenberg, JM
    Prinsen, JE
    Waalkens, HJ
    Gerritsen, J
    Knol, K
    deMonchy, JGR
    Kaptein, AA
    Dekker, FW
    Merkus, PJFM
    Hughes, MD
    Robinson, NJ
    Pocock, SJ
    Bleecker, ER
    Meyers, DA
    CHEST, 1996, 110 (01) : 35 - 41
  • [24] Asthma Therapy in Pediatric Patients: A Systematic Review of Treatment With Montelukast Versus Inhaled Corticosteroids
    Massingham, Kristen
    Fox, Shelley
    Smaldone, Arlene
    JOURNAL OF PEDIATRIC HEALTH CARE, 2014, 28 (01) : 51 - 62
  • [25] Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids
    Sano, T
    Nakamura, Y
    Yanagawa, H
    Bando, H
    Nii, A
    Yoshida, S
    Sone, S
    LUNG, 2003, 181 (04) : 227 - 235
  • [26] Withdrawal of Inhaled Corticosteroids in Patients with COPD - A Prospective Observational Study
    Nielsen, Anne Orholm
    Hilberg, Ole
    Jensen, Jens Ulrik Staehr
    Kristensen, Steffen Helmer
    Frolund, Jannie Christina
    Langkilde, Pernille Kolholt
    Lokke, Anders
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 807 - 815
  • [27] Adherence to inhaled corticosteroids: An ancillary study of the Childhood Asthma Management Program clinical trial
    Krishnan, Jerry A.
    Bender, Bruce G.
    Wamboldt, Frederick S.
    Szefler, Stanley J.
    Adkinson, N. Franklin, Jr.
    Zeiger, Robert S.
    Wise, Robert A.
    Bilderback, Andrew L.
    Rand, Cynthia S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (01) : 112 - 118
  • [28] Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
    Chen, Dennis
    Restrepo, Marcos I.
    Fine, Michael J.
    Pugh, Mary Jo V.
    Anzueto, Antonio
    Metersky, Mark L.
    Nakashima, Brandy
    Good, Chester
    Mortensen, Eric M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (03) : 312 - 316
  • [29] Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early
    Menckeberg, Tanja T.
    Hugtenburg, Jacqueline G.
    Lammers, Jan Willem
    Raaijmakers, Jan A. M.
    Bouvy, Marcel L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (02) : 277 - 281
  • [30] Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early
    Tanja T. Menckeberg
    Jacqueline G. Hugtenburg
    Jan Willem Lammers
    Jan A. M. Raaijmakers
    Marcel L. Bouvy
    International Journal of Clinical Pharmacy, 2012, 34 : 277 - 281